RYGB cuts markers of oxidative stress in subcutaneous tissue

RYGB cuts markers of oxidative stress in subcutaneous tissue

(HealthDay)—Roux-en-Y gastric bypass (RYGB) surgery attenuates markers of oxidative stress in subcutaneous adipose tissue, according to a study published online May 22 in Diabetes.

X. Julia Xu, Ph.D., from the Boston University School of Medicine, and colleagues examined how AMP-activated protein kinase (AMPK) activity, oxidative stress, and inflammation are affected by RYGB surgery. Data were included from 11 patients who were examined immediately prior to and three months after surgery.

The researchers found that AMPK activity increased 3.5-fold after surgery, and oxidative stress declined by 50 percent in . There was an 80 percent reduction in malonyl-coA levels. Patients also had improvements in their , insulin sensitivity (measured by the homeostasis model assessment), and increased circulating high molecular weight adiponectin; there was also a reduction in fasting plasma insulin levels. Postoperatively, there was no change in the expression of inflammatory markers in subcutaneous tissue, but plasma C-reactive protein was reduced by 50 percent.

"Bariatric surgery has been demonstrated to attenuate markers of in liver and plasma," the authors write. "The results of the present study indicate that it has a similar effect in subcutaneous adipose tissue."

More information: Abstract
Full Text (subscription or payment may be required)

Journal information: Diabetes

Copyright © 2015 HealthDay. All rights reserved.

Citation: RYGB cuts markers of oxidative stress in subcutaneous tissue (2015, May 29) retrieved 4 March 2024 from https://medicalxpress.com/news/2015-05-rygb-markers-oxidative-stress-subcutaneous.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Roux-en-Y surgery can reverse insulin treatment in T2DM


Feedback to editors